Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Quadriceps Tendon

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Quadriceps Tendon1
  • Control1
  • Hamstring Tendon1
  • Perturbation1

Active Sponsors

  • Arthritis Foundation1
  • Lynn Snyder-Mackler1
  • Universidad de Granada1
  • University of California, San Francisco1

Top Investigators

Activity Timeline